Resultados de procura - Parviz Ghahramani

  • Mostrando 1 - 7 Resultados de 7
Limitar resultados
  1. 1
    Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation Regimens

    Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation Regimens por Lynn Purkins, Nolan Wood, Parviz Ghahramani, Katie Greenhalgh, Michael J. Allen, Diane Kleinermans

    Publicado 2002
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration

    Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration por Lynn Purkins, Nolan Wood, Parviz Ghahramani, Edward R. Love, Malcolm D. Eve, Anitra Fielding

    Publicado 2003
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Translational Medicine definition by the European Society for Translational Medicine

    Translational Medicine definition by the European Society for Translational Medicine por Randall J. Cohrs, Tyler Martin, Parviz Ghahramani, Luc Bidaut, Paul J. Higgins, Aamir Shahzad

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Phase II Study of Efficacy, Safety, and Pharmacokinetics of Trastuzumab Monotherapy Administered on a 3-Weekly Schedule

    Phase II Study of Efficacy, Safety, and Pharmacokinetics of Trastuzumab Monotherapy Administered on a 3-Weekly Schedule por José Baselga, Xavier Carbonell, Noel-Jaime Castañeda-Soto, Michael Clemens, Michael Green, Vernon Harvey, Serafín Morales, Claire Barton, Parviz Ghahramani

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer

    Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer por U. Gatzemeier, G. Groth, Charles Butts, Nico van Zandwijk, Frances A. Shepherd, Andrea Ardizzoni, Claire Barton, Parviz Ghahramani, Vera Hirsh

    Publicado 2003
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Clinical Relevance of Dissolution Testing in Quality by Design

    Clinical Relevance of Dissolution Testing in Quality by Design por Paul A. Dickinson, Wang Wang Lee, Paul W. Stott, Andy I. Townsend, J.P. Smart, Parviz Ghahramani, Tracey Hammett, Linda Billett, Sheena Behn, Ryan C. Gibb, Bertil Abrahamsson

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO

    Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO por Ragy R. Girgis, Mark Slifstein, Deepak Cyril D’Souza, Yih Lee, Antonia Periclou, Parviz Ghahramani, I. Laszlovszky, Suresh Durgam, Nika Adham, Nabeel Nabulsi, Yiyun Huang, Richard E. Carson, Béla Kiss, Margit Kapás, Anissa Abi‐Dargham, Ashok Rakhit

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: